Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients

Journal Title: International Journal of Cancer Management - Year 2017, Vol 10, Issue 4

Abstract

Introduction The endometrial cancer (EC) is the seventh most common malignancies worldwide among females with good prognosis in early stages of the disease. The CpG Island in the promoter region of tumor-suppressor genes are frequently methylated in various types of human cancers. In the present study, we investigated the methylation pattern in promoter region of <i>RASSF1A</i> and RASSF2A genes in Endometrial cancer patients in Iranian women to identify correlations among promoter hypermethylation, disease risk and clinicopathological parameters. Methods 28 patients and 22 healthy controls were studied. Isolation of genomic DNA from FFPE and peripheral blood was performed and Methylation-Specific PCR (MSP) was applied for analysis of the promoter CpG methylation status of <i>RASSF1A</i> and RASSF2A genes in the studied population. Results A significant difference was found among the study groups and the presence of promoter CpG hypermethylation status in the <i>RASSF1A</i> (P = 0.0321) and <i>RASSF2A </i>(P = 0.0003) genes. <i>RASSF1A</i>, and <i>RASSF2A</i> gene promoter methylations were present in 53.57% and 42.85% of EC samples when compared to those in the controls with 31.81% and 9.09% respectively. Furthermore, methylation status between tissue and blood samples of <i>RASSF1A</i>, and RASSF2A genes was not significant (P = 0.49 and 0.09 respectively). Our results indicated a corollation between ages, menosososal state and tumor grade with <i>RASSF1A</i>, and <i>RASSF2A</i> promoter methylation. Conclusions In our study, Hypermethylation of both <i>RASSF1A</i> and <i>RASSF2A</i> genes are important events in carcinogenesis of endometrial cancer. Epigenetic alternations may have diagnostic value for early diagnosis and better clicinal management of susceptibility to endometrial malignancies.

Authors and Affiliations

Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam, Khadijeh Elmizadeh

Keywords

Related Articles

Extracranial Extrarenal Rhabdoid Tumor: A Case Report

Introduction Rhabdoid Tumor is one of the rare and aggressive malignant tumors of childhood that was introduced as a subgroup of the rhabdomyosarcomatoid of the Wilm’s tumor in 19...

Clinical Value of Human Leucocyte Antigen G (HLA-G) Expression in the Prognosis of Colorectal Cancer

Objectives Overexpression of human leukocyte antigen G (HLA-G) in several malignant tumors has been reported. The aim of our study was to investigate HLA-G expression in colorecta...

A Comparative Study of FIGO 1988 Versus 2009 Staging for Endometrial Carcinoma

Objectives: The aim of this study was to investigate the benefits of the newly revised “The international federation of gynecology and obstetrics (FIGO), 2009” sytem and whether there was a difference in new system compa...

The Role of Echocardiography in Detection of Chemotherapy-Induced Cardiotoxicity in Breast Cancer Patients

Context: The incidence of breast malignancy is increasing and it became evident that chemotherapy protocols that are based on anthracyclinesandtrastuzumab, which are being used in these patients, have cardiotoxic effect....

Simultaneous Occurrence of B-Cell Lymphocytic Leukemia and Acute Myeloid Leukemia in an Elderly Female Patient

Introduction The coexistence of B-cell chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) in the same patient is rare. The aim of this study is to report of simul...

Download PDF file
  • EP ID EP237357
  • DOI 10.5812/ijcm.8629
  • Views 65
  • Downloads 0

How To Cite

Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam, Khadijeh Elmizadeh (2017). Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients. International Journal of Cancer Management, 10(4), -. https://europub.co.uk/articles/-A-237357